We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Successful conversion surgery following chemotherapy with an immune checkpoint inhibitor in an older adult patient with stage IVB esophageal squamous cell carcinoma: a case report

    Background

    Chemotherapy and chemoradiotherapy are common treatments for esophageal squamous cell carcinoma with distant metastasis; however, the...

    Tetsuro Kawazoe, Shuhei Ito, ... Yoichi Ikeda in Surgical Case Reports
    Article Open access 30 March 2023
  2. Knockdown of RAD51AP1 suppressed cell proliferation and invasion in esophageal squamous cell carcinoma

    Background

    Esophageal cancer is a common malignant tumor of digestive tract with esophageal squamous cell carcinoma (ESCC) being the main histological...

    Yang-Yang Hu, Chen-Chao Ma, Kai-**ng Ai in Discover Oncology
    Article Open access 05 October 2022
  3. Outcomes of solitary postoperative recurrence of esophageal squamous cell carcinoma diagnosed with FDG-PET/CT and treated with definitive radiation therapy

    Background

    Surgical resection of esophageal cancer is frequently performed to achieve a complete cure. However, the postoperative recurrence rate is...

    Hiroki Ihara, Kotaro Yoshio, ... Takao Hiraki in Esophagus
    Article Open access 07 April 2023
  4. Prognostic impact of perioperative change in serum p53 antibody titers in esophageal squamous cell carcinoma

    Background

    The clinical effectiveness of tumor markers for estimating prognosis in esophageal squamous cell carcinoma (ESCC) remains unclear. We...

    Ryoma Haneda, Shuhei Mayanagi, ... Yasuhiro Tsubosa in Esophagus
    Article 22 May 2023
  5. GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma

    Treating patients with esophageal squamous cell carcinoma (ESCC) is challenging due to the high chemoresistance. Growth differentiation factor 15...

    Yingxi Du, Yarui Ma, ... **aobing Wang in Frontiers of Medicine
    Article 16 December 2022
  6. Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis

    Esophageal squamous cell carcinoma (ESCC) is a prevalent malignancy of the digestive system. Hypoxia is a crucial player in tumor ferroptosis...

    Jiahang Song, Junfeng Zhang, ... **aoke Di in Oncogene
    Article 14 May 2024
  7. KLF5 promotes esophageal squamous cell cancer through the transcriptional activation of FGFBP1

    Krüpple-like factor 5 (KLF5) is a zinc-finger-containing transcription factor implicated in several human malignancies, but its potential regulatory...

    Fengyun Wang, Ming Luo, Yufeng Cheng in Medical Oncology
    Article Open access 12 December 2023
  8. COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway

    Purpose

    Esophageal squamous carcinoma (ESCC) is a gastrointestinal malignancy with a high mortality, but the tumorigenesis is still unclear,...

    **g Hu, Pengbo Li, ... Senxiang Yan in Annals of Surgical Oncology
    Article 01 March 2024
  9. Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy

    Background

    To investigate the value of [18F]FDG-PET/MRI in predicting treatment response and survival in patients with primary M0 esophageal squamous...

    Yin-Kai Chao, Chun-Bi Chang, ... Jen-Hung Wang in Cancer Imaging
    Article Open access 06 November 2023
  10. Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma

    Current clinical therapies targeting receptor tyrosine kinases including focal adhesion kinase (FAK) have had limited or no effect on esophageal...

    Jianliang Zhang, Irwin H. Gelman, ... Steven N. Hochwald in Oncogene
    Article 13 December 2022
  11. Long-term survival after pulmonary metastasectomy in patients with esophageal squamous cell carcinoma with lung metastasis

    Objectives

    Esophageal squamous cell carcinoma with pulmonary metastasis has a poor prognosis, and the only treatment modality is systemic therapy such...

    Chien-Ming Lo, Kai-Hao Chuang, ... Shau-Hsuan Li in Journal of Cardiothoracic Surgery
    Article Open access 14 October 2022
  12. Giant esophageal liposarcoma with squamous cell carcinoma resected via the cervical approach: a case report

    Background

    Liposarcoma is one of the most common soft tissue sarcomas, but is extremely rarely found in the esophagus. There have been no reports of...

    Tomohiro Okura, Yasuhiro Shirakawa, ... Shigehiro Shiozaki in Surgical Case Reports
    Article Open access 20 June 2022
  13. Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials

    Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer (EC) in Asia. It is a malignant digestive tract tumor with...

    Shuai **ao, Guo Huang, ... ** Zeng in Clinical and Translational Oncology
    Article 31 October 2022
  14. Clinicopathological and mutational analysis of esophageal basaloid squamous cell carcinoma

    Esophageal basaloid squamous cell carcinoma (EBSCC) is a poorly differentiated variant of esophageal squamous cell carcinoma (ESCC). We aimed to...

    Yuka Yanai, Takuo Hayashi, ... Tsuyoshi Saito in Virchows Archiv
    Article 31 May 2022
  15. Decoding tumor stage by peritumoral and intratumoral radiomics in resectable esophageal squamous cell carcinoma

    Purpose

    To evaluate the potential application of radiomics in predicting Tumor-Node-Metastasis (TNM) stage in patients with resectable esophageal...

    **an-Zheng Tan, Rong Ma, ... Zai-Yi Liu in Abdominal Radiology
    Article Open access 13 October 2023
  16. Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma

    Background

    Performing selective esophagectomy for locally advanced squamous cell carcinoma may spare patients morbidity, but delayed surgery may infer...

    Lye-Yeng Wong, Douglas Z. Liou, ... Mark F. Berry in Annals of Surgical Oncology
    Article 26 December 2022
  17. A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis

    Background

    Cuproptosis, a form of copper-dependent programmed cell death recently presented by Tsvetkov et al., have been identified as a potential...

    Jianan Li, Jixuan Liu, ... Wentao Zhang in Journal of Cancer Research and Clinical Oncology
    Article Open access 05 July 2023
  18. Laparoscopic versus open abdominal lymph node dissection for esophageal squamous cell carcinoma: a propensity score matching analysis

    Purpose

    To compare the short- and long-term outcomes of laparoscopic and open abdominal lymph node dissection using propensity score matching (PSM)...

    Takashi Ofuchi, Masaaki Iwatsuki, ... Hideo Baba in Surgery Today
    Article 21 May 2024
  19. Clinical Significance of Intramural Metastasis as an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma

    Background

    Although intramural metastasis (IM) in esophageal cancer is considered a poor prognostic factor, there are only limited reports detailing...

    Yuki Ushimaru, Tomoki Makino, ... Yuichiro Doki in Annals of Surgical Oncology
    Article Open access 05 June 2023
  20. Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma

    Esophageal squamous cell carcinoma (ESCC), which accounts for 90% of esophageal carcinomas, seriously endangers human health. Worse still, the 5-year...

    Wei Xu, Yang Chen, ... Zhiqiang Wang in Medical Oncology
    Article 04 July 2023
Did you find what you were looking for? Share feedback.